 | • レポートコード：MRC2303B003 • 出版社/出版日：Mordor Intelligence / 2023年3月 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：消費財 |
| Single User | ￥712,500 (USD4,750) | ▷ お問い合わせ |
| Corporate License | ￥1,312,500 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Mordor Intelligence社の市場調査書では、世界のペッサリー市場規模が予測期間中（2023～2028年）に年平均8.87％上昇すると推測されています。本調査書では、ペッサリーの世界市場を広く調査・分析をし、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、種類別（ゲルホーン、リング、ドーナツ、その他）分析、エンドユーザー別（病院内薬局、小売薬局、オンライン薬局）分析、地域別（アメリカ、カナダ、メキシコ、ドイツ、イギリス、フランス、イタリア、スペイン、中国、日本、インド、オーストラリア、韓国、中東、南アフリカ、ブラジル、アルゼンチン）分析、競争状況、市場機会・将来動向などを整理しています。また、本書には、CooperSurgical Inc.、Artisan Medical、MedGyn、Panpac Medical Corporation、Bioteque America、Personal Medical Corporation、Dr. Arabin GmbH & Co. KG、Integra Lifesciences、Bray Group Limited、Thomas Medicalなどの企業情報が含まれています。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・市場動向 ・世界のペッサリー市場規模：種類別 - ゲルホーン型ペッサリーの市場規模 - リング型ペッサリーの市場規模 - ドーナツ型ペッサリーの市場規模 - その他ペッサリーの市場規模 ・世界のペッサリー市場規模：エンドユーザー別 - 病院内薬局における市場規模 - 小売薬局における市場規模 - オンライン薬局における市場規模 ・世界のペッサリー市場規模：地域別 - 北米のペッサリー市場規模 アメリカのペッサリー市場規模 カナダのペッサリー市場規模 メキシコのペッサリー市場規模 … - ヨーロッパのペッサリー市場規模 ドイツのペッサリー市場規模 イギリスのペッサリー市場規模 フランスのペッサリー市場規模 … - アジア太平洋のペッサリー市場規模 中国のペッサリー市場規模 日本のペッサリー市場規模 インドのペッサリー市場規模 … - 南米/中東のペッサリー市場規模 南アフリカのペッサリー市場規模 ブラジルのペッサリー市場規模 アルゼンチンのペッサリー市場規模 … ・競争状況 ・市場機会・将来動向 |
The Pessary market is projected to grow with a CAGR of 8.87% during the forecast period (2023 – 2028).
The initial phase of the pandemic has had a substantial impact on the growth of the pessary market owing to the significant decline in manufacturing processes, restricted demand and supply, and restricted hospital visits to avoid contact with infectious people. The industry has witnessed a negative impact as most of the population defer prosthetic surgeries due to transportation restrictions and the fear of viral infection. This has also resulted in the postponement of procedures, which included vaginal insertion of pessary as well. With the resumed services and prosthetic procedures, the demand for pessaries for treating various pelvic floor disorders is likely to increase over the coming years.
The major factors attributing to the market’s growth include the increasing prevalence of pelvic organ prolapse, urinary incontinence in patients, increasing adoption of non-invasive treatment options, changing women’s lifestyles, and a rise in the geriatric population.
The prevalence of urinary incontinence is higher in women and elderly patients and has a negative impact on their quality of life, which is the key factor driving the growth of the market over the forecast period. The changes associated with aging in the lower urinary system, such as decreased bladder capacity and feeling of fullness, decreased rate of detrusor muscle contraction, decreased pelvic floor muscle resistance, and increased residual urine volume, are some of the factors increasing the prevalence of urinary incontinence among people. According to an article published by the National Library of Medicine in 2022, titled “Urinary Incontinence,” an estimated 423 million people experience some form of urinary incontinence worldwide. Similarly, according to the study “Prevalence and associated factors of urinary incontinence in women living in China: a literature review” published in October 2020, about 43–349 million Chinese women have experienced urinary incontinence (UI). Thus, the rising prevalence of urinary incontinence increases the demand for pessary inclusion in private, thereby increasing the market’s growth.
In addition, the increasing incidences of pelvic organ prolapse in females contribute to the pessary market’s growth. The incidences of pelvic organ prolapse increase with age and after multiple pregnancies. According to an article published by the National Center for Biotechnology Information in 2020, titled “Prevalence of pelvic organ prolapse in women, associated risk factor and impact on quality of life in rural Pakistan”, it has been observed that the prevalence of pelvic organ prolapse in women is found to be 10.3%, and 37.8% of women were having grade III and IV pelvic organ prolapse. In addition, women with four or more children had the highest rate of pelvic organ prolapse (75%), followed by women aged 36–40. (25% ). This is mainly because most prolapsed women did not seek medical care. Thus, increasing the prevalence of pelvic organ prolapse in women increases the demand for pessaries to treat pelvic organ prolapse issues in women and further increases the market growth over the forecast period.
However, patient discomfort and fear of side effects are some factors that hinder the market’s growth.
Pessary Market Trends
Ring Pessary Segment Expects to Register a High CAGR in the Forecast Period
The ring pessary segment is expected to witness significant growth over the forecast period owing to the factors such as ease of usage and patient comfort and is appropriate for all stages of pelvic organ prolapse and urinary incontinence. Ring pessaries are transvaginally implanted devices that stabilize and support the urethra and bladder neck, lengthen the urethra and provide moderate compression of the urethra against the pubic bone during increases in intra-abdominal pressure. In addition to its use in women with stress urinary incontinence, a continence ring pessary may help certain women who experience urine urgency and frequency due to pelvic organ prolapse pressure.
The rising incidences of urinary incontinence and pelvic organ prolapse increase the demand for pessaries. For instance, according to an article published by the National Center for Biotechnology Information, in 2020, it has been observed that ring pessaries are the most commonly used and recommended pessary type for stage I or II prolapse. In addition, ring pessary with support can be successfully used in patients with stage III or IV prolapse.
Moreover, the rising approvals to the pessaries to treat pelvic organ prolapse are likely to increase the demand for the segment. For instance, the Food and Drug Administration (FDA) has approved ProVate (ConTIPI), a vaginal ring pessary with a disposable applicator, for the temporary, nonsurgical management of pelvic organ prolapse in women.
Thus, the increasing incidence of urinary incontinence, pelvic organ prolapse, and rising adoption of ring pessaries due to its advantages such as ease of insertion and removal and it allows for sexual activity without removal increases the demand for the segment over the forecast period.
North America is Expected to Have the Significant Market Share
North America is anticipated to have a significant share owing to the factors such as the aging female population, lifestyle changes that cause hormonal disruptions, the rising prevalence of pelvic organ prolapse and urinary incontinence, increased health awareness, and the presence of major players.
The rising pelvic floor disorders such as the increasing prevalence of urinary incontinence and pelvic organ prolapse are the major factor driving the growth of the pessary market in the region. According to an article published by the National Center for Biotechnology Information in 2021, titled “Prevalence and trends in urinary incontinence among women in the United States”, it has been observed that urinary incontinence affects women disproportionately more than males and significantly increased among women aged 60 years and older. Similarly, according to an article published by the National Center for Biotechnology Information, in 2021, titled “Uterine Prolapse”, it has been found that 9.7% of the women aged between 20-39 years and 49.7% of the women aged above 80years are affected by pelvic organ prolapse. as per the same source, by 2050, the number of people with pelvic organ prolapse is expected to rise by 59%.
In addition, the rising aging population in the region is likely to increase the demand for pessaries. For instance, according to the United States Census Bureau, the number of women aged 65 years and above in America will double by 2030 to reach over 40 million.
Furthermore, the increasing focus of the market players on developing treatment and non-invasive medical devices for treating pelvic floor diseases is also contributing to the market’s growth. For instance, in April 2022, Cosm Medical secured USD 3.8 million to create custom medical devices for women suffering from pelvic floor disorders. This will enable Cosm to develop and launch its digital gynecology platform and gynecological prosthetics (Gynethotics). It will combine novel physiological biomarkers, artificial intelligence-driven cloud software, and 3D printing to create its custom prosthetics.
Thus, the increasing incidences of pelvic floor disorders, increasing women’s aging population, and the rising focus of players to develop non-invasive medical devices for treatment are likely to propel the market’s growth in the region over the forecast period.
Pessary Market Competitor Analysis
The pessary market is fiercely competitive, with a huge number of domestic as well as international players. New product development, mergers, acquisitions, partnerships, and collaboration are some of the primary strategic activities done by market players to withhold their positions. Some of the key players are CooperSurgical Inc., MedGyn Products Inc., Panpac Medical Corporation, Integra Lifesciences, and Dr. Arabin GmbH & Co. KG.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Prevalence of Pelvic Organ Prolapse, Urinary Incontinence and Rise in Geriatric Population
4.2.2 Increasing Adoption of Non-Invasive Treatement Options
4.2.3 Rising Concern for Women’s Health and Government Initiatives
4.3 Market Restraints
4.3.1 Patient Discomfort and Fear of Side Effects
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION (Market Size by Value – USD million)
5.1 By Type
5.1.1 Gellhorn
5.1.2 Ring
5.1.3 Donut
5.1.4 Others
5.2 By End-User
5.2.1 Hospital Pharmacies
5.2.2 Retail Pharmacies
5.2.3 Online Pharmacies
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle-East & Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle-East
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 CooperSurgical Inc.
6.1.2 Artisan Medical
6.1.3 MedGyn
6.1.4 Panpac Medical Corporation
6.1.5 Bioteque America
6.1.6 Personal Medical Corporation
6.1.7 Dr. Arabin GmbH & Co. KG
6.1.8 Integra Lifesciences
6.1.9 Bray Group Limited
6.1.10 Thomas Medical
7 MARKET OPPORTUNITIES AND FUTURE TRENDS